Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Interest & Investment Income: 2012-2024

Historic Interest & Investment Income for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Dec 2024 value amounting to $10.6 million.

  • Amphastar Pharmaceuticals' Interest & Investment Income fell 7.46% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year decrease of 19.53%. This contributed to the annual value of $10.6 million for FY2024, which is 94.39% up from last year.
  • Amphastar Pharmaceuticals' Interest & Investment Income amounted to $10.6 million in FY2024, which was up 94.39% from $5.5 million recorded in FY2023.
  • In the past 5 years, Amphastar Pharmaceuticals' Interest & Investment Income ranged from a high of $10.6 million in FY2024 and a low of $601,000 during FY2021.
  • Its 3-year average for Interest & Investment Income is $5.8 million, with a median of $5.5 million in 2023.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Interest & Investment Income crashed by 35.61% in 2020 and then skyrocketed by 313.25% in 2023.
  • Yearly analysis of 5 years shows Amphastar Pharmaceuticals' Interest & Investment Income stood at $642,000 in 2020, then fell by 6.39% to $601,000 in 2021, then surged by 119.80% to $1.3 million in 2022, then soared by 313.25% to $5.5 million in 2023, then spiked by 94.39% to $10.6 million in 2024.